Full time
Octozi
New York, NY
About Octozi Bringing a new drug to market takes over a decade and costs more than a billion dollars. A huge portion of that time and cost sits in clinical trials, where teams of medical reviewers manually comb through patient data looking for errors, inconsistencies, and safety signals before anything reaches regulators. The work is slow, expensive, and error-prone, and it has barely changed in decades. Octozi is changing that. We are building the AI-powered review platform that pharma sponsors and CROs use to clean and review clinical trial data faster and more reliably than manual review. We have signed contracts with multiple pharma customers running live studies, and we are backed by a $3M seed round. Our recent paper documents what the platform achieves on real oncology trial data: 6x faster throughput, 6.4x fewer missed errors, 15.4x fewer false queries, and an estimated $5.1M in savings per Phase III trial. The numbers come from a hybrid architecture combining LLMs,...

